Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IBD
IBD
Once a gem, now just a rock, Takeda punts PhIII IBD drug as rivals muscle ahead
Endpoints
Fri, 05/29/20 - 10:45 am
Takeda
IBD
SHP647
Shire
Lilly’s first crowdsourced digital health contest seeks solutions for IBD
Fierce Pharma
Tue, 08/20/19 - 10:59 pm
IBD
Eli Lilly
innovation challenges
innovation
digital health
Microbiome Report for Week Ending 3/9/19
CP Wire
Fri, 03/15/19 - 10:38 am
microbiome
Synlogic
AOBiome
AbbVie
Infant Bacterial Therapeutics
IBD
atopic dermatitis
Microbiome Report for Week Ending 12/1/18
CP Wire
Sat, 12/8/18 - 02:42 pm
microbiome
Evelo Biosciences
Kaleido Biosciences
Vedanta Biosciences
psoriasis
atopic dermatitis
IBD
Microbiome Report for Week Ending 12/1/18
Mon, 12/10/18 - 09:06 am
Evelo Biosciences
Kaleido Biosciences
Vedanta Biosciences
psoriasis
atopic dermatitis
IBD
Vedanta pockets $12M from Johnson & Johnson on start of microbiome drug trial
Fierce Biotech
Wed, 11/28/18 - 10:04 am
Vedanta Biosciences
JNJ
microbiome
IBD
VE202
Rebiotix and Microbiome Insights Collaborate on a Microbiome IBD Diagnostic Tool to Aid Clinical Development
CP Wire
Wed, 11/7/18 - 10:34 pm
Microbiome Insights
Rebiotix
IBD
diagnostics
microbiome
Rebiotix and Microbiome Insights Collaborate on a Microbiome IBD Diagnostic Tool to Aid Clinical Development
Wed, 11/7/18 - 10:34 pm
Microbiome Insights
Rebiotix
IBD
diagnostics
microbiome
Takeda is ready to auction off a PhIII favorite at Shire to clear the last hurdles to a $62B buyout
Enpoints
Sun, 10/28/18 - 07:47 pm
Takeda
Shire
inflammatory bowel disease
IBD
ulcerative colitis
Crohn's Disease
M&A
SHP647
Landos Biopharma Initiates Ph I Trial of First-in-class Oral Treatment for IBD
Thu, 07/12/18 - 09:17 am
Landos Biopharma
ulcerative colitis
Chron's Disease
IBD
BT-11
Microbiome startup Nextbiotix raises €7M to tackle inflammatory bowel diseases
Fierce Biotech
Thu, 07/5/18 - 10:24 pm
Nextbiotix
inflammatory bowel disease
IBD
microbiome
Genentech signs $534M deal with Microbiotica to search gut bacteria for IBD targets, new drugs
Fierce Biotech
Wed, 06/6/18 - 10:30 am
Genentech
Microbiotica
microbiome
IBD
biomarkers
CytoReason Cements Proof-of-Concept with Machine-Learning-Facilitated Biomarker Breakthrough in Inflammatory Bowel Disease
CP Wire
Mon, 04/16/18 - 04:18 pm
CytoReason
IBD
inflammatory bowel disease
biomarkers
CytoReason Cements Proof-of-Concept with Machine-Learning-Facilitated Biomarker Breakthrough in Inflammatory Bowel Disease
Mon, 04/16/18 - 01:29 pm
CytoReason
IBD
Takeda teams with Cedars Sinai on tech tool to personalize IBD treatment choices
Fierce Pharma
Thu, 02/8/18 - 09:16 am
drug marketing
Takeda
Cedars Sinai
IBD
mobile apps
With help from J&J, upstart Provention lands rights to two mid-stage IBD drugs and shoots for PhII
Endpoints
Thu, 09/21/17 - 08:49 am
JNJ
Provention Bio
IBD
inflammatory bowel disease
PRV-6527
Crohn's Disease
PRV-300
ulcerative colitis
Synergy Pharmaceuticals begins Phase Ib trial of SP-333
Yahoo/Fly on the Wall
Mon, 01/28/13 - 10:54 am
SP-333
Synergy Pharmaceuticals
IBD
inflammatory bowel disease
IND Submission by Synergy Pharma
Yahoo/Zacks
Tue, 09/18/12 - 10:40 am
Synergy Pharmaceuticals
SP-333
IBD
inflammatory bowel disease
Pages
« first
‹ previous
1
2